American Journal of Tropical Medicine and Hygiene
October 2014; 91 (4)
http://www.ajtmh.org/content/current

Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet
Bhushan R. Deshpande, Sowmya R. Rao, Emily S. Jentes, Susan L. Hills, Marc Fischer, Mark D. Gershman, Gary W. Brunette, Edward T. Ryan, Regina C. LaRocque, and the Global TravEpiNet Consortium
Am J Trop Med Hyg 2014 91:694-698; Published online July 28, 2014, doi:10.4269/ajtmh.14-0062
Abstract
Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.